Welcome to Lamellar Biomedical

Lamellar is developing a range of patent protected medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies. Diseases which may benefit from the application of mimetic Lamellar bodies include Dry Mouth, Dry Eye and Cystic Fibrosis. All these conditions are poorly served by current medications and represent areas of high value unmet medical need.

Learn more

Research & Development

Lamellar in partnership with clinical centres-of-excellence is highly advanced in developing novel products for Dry Mouth, Dry Eye and Cystic Fibrosis.

Learn more

Investors

Lamellar Biomedical Shareholders comprise both institutional and private investors.

Learn more

News & Press

What has been going on at Lamellar?

Learn more

Lamellar Biomedical

A privately held, innovative, biotechnology company bringing new patent protected medical products to the healthcare market.

Strategic Goals

To develop Lamellar technology to address areas of high medical cost and unmet medical need.

Product pipeline

Lamellar's patented technology covers an extensive range of therapeutic areas.